Blog
Donate
Blog
Donate
Patients & Caregivers
Let Us Support You
What is AE?
Symptoms
Diagnosis
Treatment
Recovery
Living with AE
Professionals
How We Can Support You
Join the Clinicians Network
Attend AEA Provider Monthly Education Series
Provider Resources
Research
Research In AE
Apply for a Grant
AEA Research Network
Make a Difference
AE Today
AE Tomorrow
How Can You Help?
News & Support
News
Support
Media Kit
About
AE Alliance
Living with AE Advisory Council
Staff
Board of Directors
Medical Advisory Board
Financials
Blog
Contact
Search
Antiepileptic drug therapy in autoimmune epilepsy associated with antibodies targeting the leucine-rich glioma-inactivated protein 1
February 27, 2021
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6119747/
by
aealliance
Research
Resources
Clinical characteristics and short-term prognosis of LGI1 antibody encephalitis: a retrospective case study
Randomized Placebo-Controlled Trial of Intravenous Immunoglobulin in Autoimmune LGI1/CASPR2 Epilepsy
